LANXESS AG UNSP.ADR 1/5 Net Assets
LANXESS AG UNSP.ADR 1/5 net assets. Based on the latest financial reports, LANXESS AG UNSP.ADR 1/5 (LX9B) has net assets worth €3.91 Billion EUR (≈ $4.57 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.18 Billion ≈ $9.57 Billion USD) and total liabilities (€4.28 Billion ≈ $5.00 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See debt-free asset ratio of LANXESS AG UNSP.ADR 1/5 to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.91 Billion |
| % of Total Assets | 47.76% |
| Annual Growth Rate | 6.87% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 7.46 |
Net Assets of LANXESS AG UNSP.ADR 1/5 (2021–2024)
Net assets of LANXESS AG UNSP.ADR 1/5 from 2021 to 2024. This chart illustrates how LANXESS AG UNSP.ADR 1/5's net assets have evolved over time, based on quarterly financial data. Also explore net asset growth rate of LANXESS AG UNSP.ADR 1/5 to track the company's year-over-year net asset growth rate.
Annual Net Assets for LANXESS AG UNSP.ADR 1/5 (2021–2024)
The table below shows the annual net assets of LANXESS AG UNSP.ADR 1/5 from 2021 to 2024. For live market cap and overall valuation, see market value of LANXESS AG UNSP.ADR 1/5.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €4.59 Billion ≈ $5.37 Billion |
+1.89% |
| 2023-12-31 | €4.51 Billion ≈ $5.27 Billion |
+1.81% |
| 2022-12-31 | €4.43 Billion ≈ $5.18 Billion |
+17.68% |
| 2021-12-31 | €3.76 Billion ≈ $4.40 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to LANXESS AG UNSP.ADR 1/5's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 166.3% over the analyzed period, potentially due to dividend distributions or operating losses.
LANXESS AG UNSP.ADR 1/5 Net Assets Breakdown (December 2024)
LANXESS AG UNSP.ADR 1/5 net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €4.76 Billion | 103.86% |
| Total Equity | €4.59 Billion | 100.00% |
LANXESS AG UNSP.ADR 1/5 Competitors by Market Cap
The table below lists competitors of LANXESS AG UNSP.ADR 1/5 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SES S. A.
PA:SESG
|
$1.72 Billion |
|
Xiamen ITG Group Corp Ltd
SHG:600755
|
$1.72 Billion |
|
Shanghai Feilo Acoustics Co Ltd
SHG:600651
|
$1.72 Billion |
|
Boston Beer Company Inc
NYSE:SAM
|
$1.72 Billion |
|
Cloetta AB (publ)
ST:CLA-B
|
$1.72 Billion |
|
Sirius Real Estate Ltd
JSE:SRE
|
$1.72 Billion |
|
Braveheart Bio, Inc. Common Stock
NASDAQ:BRVE
|
$1.72 Billion |
|
Hope Bancorp Inc
NASDAQ:HOPE
|
$1.72 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LANXESS AG UNSP.ADR 1/5's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,501,000,000 to 4,586,000,000, a change of 85,000,000 (1.9%).
- Net loss of 177,000,000 reduced equity.
- Dividend payments of 9,000,000 reduced retained earnings.
- Other factors increased equity by 271,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-177.00 Million | -3.86% |
| Dividends Paid | €9.00 Million | -0.2% |
| Other Changes | €271.00 Million | +5.91% |
| Total Change | €- | 1.89% |
Book Value vs Market Value Analysis
This analysis compares LANXESS AG UNSP.ADR 1/5's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.07x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €43.50 | €3.48 | x |
| 2022-12-31 | €51.20 | €3.48 | x |
| 2023-12-31 | €52.13 | €3.48 | x |
| 2024-12-31 | €53.11 | €3.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LANXESS AG UNSP.ADR 1/5 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.78%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 2.12x
- Recent ROE (-3.86%) is below the historical average (4.69%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 7.11% | 4.38% | 0.58x | 2.80x | €-108.60 Million |
| 2022 | 5.65% | 3.09% | 0.72x | 2.55x | €-192.10 Million |
| 2023 | 9.84% | 6.60% | 0.69x | 2.15x | €-7.10 Million |
| 2024 | -3.86% | -2.78% | 0.66x | 2.12x | €-635.60 Million |
Industry Comparison
This section compares LANXESS AG UNSP.ADR 1/5's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $790,099,228
- Average return on equity (ROE) among peers: -433.20%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LANXESS AG UNSP.ADR 1/5 (LX9B) | €3.91 Billion | 7.11% | 1.09x | $1.72 Billion |
| LIFELINE SPAC I OYJ A EO1 (0CD) | $2.38 Million | -65.24% | 41.76x | $181.76 Million |
| GRAPHENE MANUFACT.GROUP (0GF) | $2.03 Million | 0.00% | 1.43x | $185.36 Million |
| Orion Engineered Carbons SA (0OE) | $319.70 Million | 42.13% | 4.10x | $305.89 Million |
| COVESTRO AG SP.ADR 1/2 (1CO1) | $7.12 Billion | -3.82% | 1.05x | $11.11 Billion |
| H&R GmbH & Co. KGaA (2HRA) | $241.14 Million | 15.96% | 1.63x | $183.88 Million |
| LOOP INDUSTRIES DL-001 (3L9) | $367.00K | -4102.72% | 49.62x | $11.76 Million |
| Dotz Nano Ltd (57N) | $3.79 Million | -160.22% | 0.25x | $4.51 Million |
| TIDEWATER RENEWABLES LTD (7GZ) | $155.20 Million | 2.26% | 1.56x | $409.20 Million |
| DIRECTA PLUS PLC LS-0025 (88K) | $16.03 Million | -22.78% | 0.36x | $2.35 Million |
| TEKNA HOLDING ASA NK 2 (8VB) | $38.35 Million | -37.60% | 0.99x | $67.10 Million |
About LANXESS AG UNSP.ADR 1/5
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative soluti… Read more